(Q28200068)

7 January 2021

Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia

1 reference

7 January 2021

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

1 reference

7 January 2021

Chemokines and chemokine receptors in model neurological pathologies: molecular and immunocytochemical approaches

1 reference

7 January 2021

MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation

1 reference

7 January 2021

Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Chemokine expression in murine experimental allergic encephalomyelitis

1 reference

7 January 2021

Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

1 reference

7 January 2021

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

1 reference

7 January 2021

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

1 reference

7 January 2021

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

1 reference

7 January 2021

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

1 reference

7 January 2021

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

1 reference

7 January 2021

Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases.

1 reference

7 January 2021

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.

1 reference

7 January 2021

Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue

1 reference

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

7 January 2021

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

1 reference

7 January 2021

The CCR5 deletion mutation fails to protect against multiple sclerosis

1 reference

7 January 2021

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group

1 reference

7 January 2021

Chemokines and their receptors in allograft rejection

1 reference

7 January 2021

Current understanding of chemokine involvement in allograft transplantation.

1 reference

7 January 2021

Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy

1 reference

7 January 2021

Intragraft expression of chemokine gene occurs early during acute rejection of allogeneic cardiac grafts

1 reference

7 January 2021

Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts

1 reference

7 January 2021

Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells.

1 reference

7 January 2021

Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells

1 reference

7 January 2021

Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection

1 reference

7 January 2021

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

1 reference

7 January 2021

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

7 January 2021

Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis

1 reference

7 January 2021

Interferon-γ elicits arteriosclerosis in the absence of leukocytes

1 reference

7 January 2021

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

7 January 2021

Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus.

1 reference

7 January 2021

CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis

1 reference

7 January 2021

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1

1 reference

7 January 2021

Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines

1 reference

7 January 2021

Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells

1 reference

7 January 2021

The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness

1 reference

7 January 2021

The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3

1 reference

7 January 2021

Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI

1 reference

7 January 2021

CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo

1 reference

7 January 2021

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model

1 reference

7 January 2021

The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats

1 reference

7 January 2021

Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice

1 reference

7 January 2021

The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines

1 reference

7 January 2021

Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium.

1 reference

7 January 2021

Mig, GRO alpha and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis

1 reference

7 January 2021

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

7 January 2021

Cytokine, activation marker, and chemokine receptor expression by individual CD4(+) memory T cells in rheumatoid arthritis synovium

1 reference

7 January 2021

Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis

1 reference

7 January 2021

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

7 January 2021

Association of rheumatoid arthritis with a functional chemokine receptor, CCR5

1 reference

7 January 2021

GROWTH-PROMOTING FUNCTION OF LEUCOCYTES

1 reference

7 January 2021

Regulation of the macrophage content of neoplasms by chemoattractants

1 reference

7 January 2021

Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues.

1 reference

7 January 2021

Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE.

1 reference

7 January 2021

Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas

1 reference

7 January 2021

Suppression of tumor formation in vivo by expression of the JE gene in malignant cells

1 reference

7 January 2021

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

1 reference

7 January 2021

Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth

1 reference

7 January 2021

Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms

1 reference

7 January 2021

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

1 reference

7 January 2021

Combined chemokine and cytokine gene transfer enhances antitumor immunity

1 reference

7 January 2021

The functional role of the ELR motif in CXC chemokine-mediated angiogenesis

1 reference

7 January 2021

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

1 reference

7 January 2021

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

1 reference

7 January 2021

Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin

1 reference

7 January 2021

Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1

1 reference

7 January 2021

Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways

1 reference

7 January 2021

Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells

1 reference

7 January 2021

Functional expression of chemokine receptor CXCR4 on human epithelial cells

1 reference

7 January 2021

CCR3 mRNA expression in bronchial epithelial cells and various cells in allergic inflammation

1 reference

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

7 January 2021

Molecular mediators of arterial inflammation: a role for microbial products?

1 reference

7 January 2021

The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration

1 reference

7 January 2021

Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells

1 reference

7 January 2021

Interleukin-8 and its receptor CXCR2 in atherosclerosis

1 reference

7 January 2021

The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques.

1 reference

7 January 2021

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

1 reference

7 January 2021

CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells

1 reference

7 January 2021

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice

1 reference

7 January 2021

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

1 reference

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

7 January 2021

Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

7 January 2021

CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension

1 reference

7 January 2021

Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

1 reference

7 January 2021

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

7 January 2021

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions

1 reference

7 January 2021

Local expression of inflammatory cytokines in human atherosclerotic plaques

1 reference

7 January 2021

Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation

1 reference

7 January 2021

Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.

1 reference

7 January 2021

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

7 January 2021

Inhibition of monocyte chemotactic protein-1 synthesis by statins

1 reference

7 January 2021

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

1 reference

7 January 2021

Identifiers

DOI

10.1038/84209

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

354593

1034992744

0 references

354593

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference